Fusion Pharmaceuticals (FUSN US)

Fusion Pharmaceuticals Inc. operates as a biopharmaceutical company. The Company discovers and develops novel targeted alpha therapeutics (TAT) and radiopharmaceuticals for the diagnosis and treatment of chemotherapy resistant cancers. Fusion Pharmaceuticals serves health care sectors in Canada.